Niagen Bioscience, Inc. — Director's Dealing 2017

May 11, 2017

SEC Form 3/A — Form 3/A

Issuer: ChromaDex Corp. (CDXC)
CIK: 0001386570
Period of Report: 2017-04-26

Reporting Person: Champion River Ventures Ltd (10% Owner)
Reporting Person: Prime Tech Global Ltd (10% Owner)
Reporting Person: Mayspin Management Ltd (10% Owner)
Reporting Person: Li Ka Shing (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	807692	Direct

Footnotes

F1: Champion River Ventures Limited (the "Champion River") acquired 807,692 shares of the Issuer's common stock at the closing of the first tranche pursuant to the Securities Purchase Agreement, dated April 26, 2017 (the "SPA"), by and among the Issuer, Champion River and Pioneer Step Holdings Limited ("Pioneer"). Pursuant to the SPA, at the closing of the second tranche, which is expected to close within 30 days of the closing of the first tranche, Champion River and Pioneer have the right to acquire an additional 6,303,814 shares of common stock of the Issuer, with the allocation of such shares between Champion River and Pioneer to be mutually agreed upon by Champion River and Pioneer at the closing of the second tranche.

F2: The shares are held directly by Champion River. The sole shareholder of Champion River is Prime Tech Global Limited ("Prime Tech"), the sole shareholder of Prime Tech is Mayspin Management Limited ("Mayspin"), and the sole shareholder of Mayspin is Li Ka Shing ("Li Ka Shing"). Each of Prime Tech, Mayspin and Li Ka Shing disclaims Section 16 beneficial ownership of the securities held by Champion River, except to the extent of its pecuniary interest therein, if any.